首页 | 本学科首页   官方微博 | 高级检索  
检索        

GSK1838705A对胰腺癌细胞增殖和凋亡的影响
引用本文:吴宏奎,刘宁,杨星,宋少伟.GSK1838705A对胰腺癌细胞增殖和凋亡的影响[J].现代肿瘤医学,2017(13):2031-2035.
作者姓名:吴宏奎  刘宁  杨星  宋少伟
作者单位:中国医科大学附属第一医院胰胆外科,辽宁沈阳,110001
基金项目:国家自然科学基金资助项目(81301767)
摘    要:目的:研究胰岛素样生长因子1受体抑制剂GSK1838705A对人胰腺癌细胞的抗肿瘤作用.方法:Cell Counting Kit-8(CCK-8)方法检测不同浓度GSK1838705A对胰腺癌CAPAN-2细胞增殖能力的影响;流式细胞术检测GSK1838705A对CAPAN-2细胞凋亡的影响;Western blot方法检测GSK1838705A作用于胰腺癌CAPAN-2细胞后Bax和Cytochrome C蛋白表达水平的变化;划痕试验观察GSK1838705A处理CAPAN-2细胞后对细胞生长及迁移的影响.结果:CCK-8检测结果表明不同浓度GSK1838705A能够不同程度抑制胰腺癌CAPAN-2细胞的增殖,当药物浓度达10 μmol/L时,其抑制率可达98.29%;流式结果显示,GSK1838705A可诱导CAPAN-2细胞发生凋亡,随着GSK1838705A浓度的增加,诱导凋亡作用增强;Western blot结果显示,Bax和Cytochrome C蛋白表达水平升高;划痕试验结果表明,不同浓度GSK1838705A能够不同程度抑制CAPAN-2细胞的增殖和迁移.结论:胰岛素样生长因子1受体抑制剂GSK1838705A在体外可显著抑制胰腺癌CAPAN-2细胞的增殖,诱导细胞凋亡并抑制细胞迁移,在胰腺癌细胞中发挥着显著的抗肿瘤作用.

关 键 词:GSK1838705A  胰腺癌  胰岛素样生长因子1受体  抗肿瘤作用

Effects of GSK1838705A on proliferation and apoptosis of pancreatic cancer cells
Wu Hongkui,Liu Ning,Yang Xing,Song Shaowei.Effects of GSK1838705A on proliferation and apoptosis of pancreatic cancer cells[J].Journal of Modern Oncology,2017(13):2031-2035.
Authors:Wu Hongkui  Liu Ning  Yang Xing  Song Shaowei
Abstract:Objective:To examine the anti-tumor effects of insulin-like growth factor 1 receptor inhibitor of GSK1838705A on human pancreatic cancer cells.Methods:Cell Counting Kit-8 (CCK-8) method was used to detect the effect of different concentrations of GSK1838705A on proliferation of pancreatic cancer cell line CAPAN-2 in vitro.To examine the effect of GSK1838705A on apoptosis of CAPAN-2 cells by flow cytometry.Detection of Bax and Cytochrome C protein expression in pancreatic cancer CAPAN-2 cells by Western blot method after GSK1838705A.Scratch test was to observe the effect of GSK1838705A on cell growth and migration.Results:CCK-8 results showed that different concentration of GSK 18 3 8705 A could inhibit the proliferation of pancreatic cancer CAPAN-2 cells in different degrees.The inhibition rate was up to 98.29% when the drug concentration reached 10 μmol/L.Flow cytometry indicated that GSK1838705A could induce the apoptosis of CAPAN-2 cells,and the effect was enhanced with the increase of GSK1838705A concentration.Western blot results marked the Bax and Cytochrome C proteins' expression levels were increased.Scratch test demonstrated the proliferation and migration of CAPAN-2 cells were inhibited by different concentrations of GSK1838705A in different degrees.Conclusion:Insulin-like growth factor 1 receptor inhibitor of GSK1838705A,playing a significant anti-tumor role in pancreatic cancer cells of CAPAN-2 which in vitro,can significantly inhibit the proliferation,induce apoptosis and inhibit cell migration of pancreatic cancer CAPAN-2 cells.
Keywords:GSK1838705 A  pancreatic cancer  insulin-like growth factor 1 receptor  anti-tumor effect
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号